164 related articles for article (PubMed ID: 32620415)
1. Tamoxifen maculopathy: The importance of screening and long follow-up.
Zamorano Martín F; Rocha-de-Lossada C; Rachwani Anil R; Borroni D; Rodriguez Calvo de Mora M; España Contreras M
J Fr Ophtalmol; 2020 Oct; 43(8):727-730. PubMed ID: 32620415
[TBL] [Abstract][Full Text] [Related]
2. Crystalline deposits in the macula - tamoxifen maculopathy or macular telangiectasia?
Rijal RK; Nakhwa C; Sindal MD
Nepal J Ophthalmol; 2014; 6(2):227-9. PubMed ID: 25680254
[TBL] [Abstract][Full Text] [Related]
3. Crystalline maculopathy: a rare complication of tamoxifen therapy.
Srikantia N; Mukesh S; Krishnaswamy M
J Cancer Res Ther; 2010; 6(3):313-5. PubMed ID: 21119261
[TBL] [Abstract][Full Text] [Related]
4. Pseudocystic foveal cavitation in tamoxifen retinopathy.
Doshi RR; Fortun JA; Kim BT; Dubovy SR; Rosenfeld PJ
Am J Ophthalmol; 2014 Jun; 157(6):1291-1298.e3. PubMed ID: 24582991
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen induced maculopathy presenting like macular telangiectasia type 2 in a patient with breast cancer.
Ansari Astaneh MR; Shokoohi Rad S; Ghavami Shahri SH; Heidarzadeh HR
J Oncol Pharm Pract; 2023 Mar; 29(2):489-492. PubMed ID: 35730198
[TBL] [Abstract][Full Text] [Related]
6. The eyes have it! Tamoxifen maculopathy revisited: a case report.
Nair AG; Das D; Goyal A; Gandhi RA
J Ocul Pharmacol Ther; 2012 Dec; 28(6):640-2. PubMed ID: 22731242
[TBL] [Abstract][Full Text] [Related]
7. [Optical coherence tomography study in tamoxifen maculopathy].
Baget-Bernaldiz M; Soler Lluis N; Romero-Aroca P; Traveset-Maeso A
Arch Soc Esp Oftalmol; 2008 Oct; 83(10):615-8. PubMed ID: 18855282
[TBL] [Abstract][Full Text] [Related]
8. [Tamoxifen-induced toxic maculopathy at low cumulative dose : The value of multimodal imaging].
Plas H; Agard É; Chehab HE; Levron A; Bouvarel H; Chirpaz N; Rochet E; Billant J; Dot C
J Fr Ophtalmol; 2022 Dec; 45(10):e450-e454. PubMed ID: 35906136
[No Abstract] [Full Text] [Related]
9. Optical coherence tomography findings in tamoxifen retinopathy.
Gualino V; Cohen SY; Delyfer MN; Sahel JA; Gaudric A
Am J Ophthalmol; 2005 Oct; 140(4):757-8. PubMed ID: 16226541
[TBL] [Abstract][Full Text] [Related]
10. Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy.
Bourla DH; Sarraf D; Schwartz SD
Am J Ophthalmol; 2007 Jul; 144(1):126-8. PubMed ID: 17601434
[TBL] [Abstract][Full Text] [Related]
11. OCT Angiography Findings of Tamoxifen Retinopathy: Similarity with Macular Telangiectasia Type 2.
Lee S; Kim HA; Yoon YH
Ophthalmol Retina; 2019 Aug; 3(8):681-689. PubMed ID: 31068263
[TBL] [Abstract][Full Text] [Related]
12. To stop or not? Tamoxifen therapy for secondary prevention of breast cancer in a patient with ocular toxicity.
Bommireddy T; Carrim ZI
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26759403
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen side effects, age-related macular degeneration (AMD) or cancer associated retinopathy (CAR)?
Sadowski B; Kriegbaum C; Apfelstedt-Sylla E
Eur J Ophthalmol; 2001; 11(3):309-12. PubMed ID: 11681514
[TBL] [Abstract][Full Text] [Related]
14. [Unusual symptoms for tamoxifen-associated maculopathy].
Hager T; Hoffmann S; Seitz B
Ophthalmologe; 2010 Aug; 107(8):750-2. PubMed ID: 20393723
[TBL] [Abstract][Full Text] [Related]
15. SPECTRAL DOMAIN VERSUS SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE RETINAL CAPILLARY PLEXUSES IN SICKLE CELL MACULOPATHY.
Jung JJ; Chen MH; Frambach CR; Rofagha S; Lee SS
Retin Cases Brief Rep; 2018 Spring; 12(2):87-92. PubMed ID: 27749746
[TBL] [Abstract][Full Text] [Related]
16. Spectral Domain OCT Imaging Techniques in Tamoxifen Retinopathy.
Neuville J; Yevseyenkov V
Optom Vis Sci; 2015 Feb; 92(2):e55-9. PubMed ID: 25525894
[TBL] [Abstract][Full Text] [Related]
17. Ocular side-effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow-up study.
Parkkari M; Paakkala AM; Salminen L; Holli K;
Acta Ophthalmol Scand; 2003 Oct; 81(5):495-9. PubMed ID: 14510798
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of spectral-domain optical coherence tomography features in assessment of visual prognosis in eyes with acute welding arc maculopathy.
Zhang C; Dang G; Zhao T; Wang D; Su Y; Qu Y
Int Ophthalmol; 2019 May; 39(5):1081-1088. PubMed ID: 29651692
[TBL] [Abstract][Full Text] [Related]
19. Optical Coherence Tomography Angiography and En Face Optical Coherence Tomography Features of Paracentral Acute Middle Maculopathy.
Sridhar J; Shahlaee A; Rahimy E; Hong BK; Khan MA; Maguire JI; Dunn JP; Mehta S; Ho AC
Am J Ophthalmol; 2015 Dec; 160(6):1259-1268.e2. PubMed ID: 26386158
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen maculopathy.
Alwitry A; Gardner I
Arch Ophthalmol; 2002 Oct; 120(10):1402. PubMed ID: 12365930
[No Abstract] [Full Text] [Related]
[Next] [New Search]
